Reporting of Drug Expenditures in the MCBS.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Poisal, John A.
  • Source:
    Health Care Financing Review. Winter2003, Vol. 25 Issue 2, p23-36. 14p. 8 Charts, 2 Graphs.
  • Additional Information
    • Subject Terms:
      DRUG utilization; MEDICAL care costs; DRUGSTORES; MEDICAL care use; PHARMACEUTICAL services; PHARMACEUTICAL industry
    • Abstract:
      Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by 17 percent and the number of prescriptions used is underreported by 17.7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Health Care Financing Review is the property of HCFA ORDS Publications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)